Dr. Reddy's Laboratories Ltd. NSE: DRREDDY | BSE: 500124

Turnaround Potential

Download real time

1321.70 -1.00 (-0.08%)

29.58% Gain from 52W Low

1.5M

NSE+BSE Volume

NSE 19 Sep, 2025 3:31 PM (IST)

Dr. Reddy's Laboratories Ltd. share price target

Dr. Reddy's Laboratories Ltd. has an average share price target of 1278.56. The consensus estimate represents a downside of -3.26% from the last price of 1321.70. View 18 reports from 9 analysts offering long-term price targets for Dr. Reddy's Laboratories Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	22 Sep 2025	Dr. Reddy's Labs	Consensus Share Price Target	1321.70	1285.13	-	-2.77	hold	pdf Detailed Estimates
	24 Aug 2023	Dr. Reddy's Labs	Geojit BNP Paribas Reco Target	1321.70	6212.00	5907.15 (-77.63%)	Target met	Hold	pdf post cache		Broker Report DR. REDDY'S LABORATARIES Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	Axis Direct Target	1321.70	6000.00	5507.00 (-76.00%)	Target met	Hold	pdf post cache		Broker Report Result Update:Dr Reddys Labs Axis Direct We have HOLD on the stock pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	Prabhudas Lilladhar Target	1321.70	5150.00	5507.00 (-76.00%)	Pre-Bonus/ Split	Sell	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	ICICI Securities Limited Reco Target	1321.70	6000.00	5475.65 (-75.86%)	Target met	Accumulate	pdf post cache		Broker Report Better volumes in US drives margins ICICI Securities Limited Dr. Reddy’s (DRL) delivered a strong beat in EBITDA and profit, driven by incremental sales from its base product portfolio and gRevlimid in the US. gRevlimid continues to lift overall margins; however, additional sales from products that are in shortage in the US improved base business margins in Q1FY24. pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	SMC online	1321.70		5507.00 (-76.00%)	Pre-Bonus/ Split	Results Update	pdf post cache		Broker Report Dr. Reddys Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	27 Jul 2023	Dr. Reddy's Labs	Motilal Oswal Target	1321.70	5240.00	5507.00 (-76.00%)	Target met	Neutral	pdf post cache		Broker Report Sharp off-take in NA/Russia drive earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	04 Jul 2023	Dr. Reddy's Labs	Sharekhan Target	1321.70	5963.00	5178.35 (-74.48%)	Target met	Buy	pdf post cache		Broker Report Dr Reddys Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	23 Jun 2023	Dr. Reddy's Labs	Motilal Oswal Target	1321.70	4680.00	4993.90 (-73.53%)	Pre-Bonus/ Split	Neutral	pdf post cache		Broker Report Robust show in FY23; but outlook subdued Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	SMC online	1321.70		4532.00 (-70.84%)	Pre-Bonus/ Split	Results Update	pdf post cache		Broker Report Dr. Reddys Laboratories SMC online pdf Copy Link Share on Share on Share on Share on Alert
	11 May 2023	Dr. Reddy's Labs	Prabhudas Lilladhar Reco Target	1321.70	4500.00	4532.00 (-70.84%)	Target met	Sell	pdf post cache		Broker Report DR REDDY'S LABS Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners